Kura Oncology (KURA) Short Interest Ratio & Short Volume $6.24 +0.04 (+0.65%) Closing price 04:00 PM EasternExtended Trading$6.45 +0.21 (+3.37%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Kura Oncology Short Interest DataKura Oncology (KURA) has a short interest of 8.28 million shares. This marks a -4.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.1, indicating that it would take 6.1 days of the average trading volume of 1.18 million shares to cover all short positions.Current Short Interest8,280,000 sharesPrevious Short Interest8,680,000 sharesChange Vs. Previous Month-4.61%Dollar Volume Sold Short$54.32 millionShort Interest Ratio6.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares86,575,000 sharesPercentage of Shares Shorted9.56%Today's Trading Volume843,603 sharesAverage Trading Volume1,184,603 sharesToday's Volume Vs. Average71% Short Selling Kura Oncology? Sign up to receive the latest short interest report for Kura Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKURA Short Interest Over TimeKURA Days to Cover Over TimeKURA Percentage of Float Shorted Over Time Kura Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20258,280,000 shares $54.32 million -4.6%N/A6.1 $6.56 4/15/20258,680,000 shares $52.34 million -1.4%11.8%5.9 $6.03 3/31/20258,800,000 shares $58.08 million -2.4%12.0%6 $6.60 3/15/20259,020,000 shares $64.40 million -2.1%12.3%5.6 $7.14 2/28/20259,210,000 shares $71.01 million -0.4%12.5%5.6 $7.71 2/15/20259,250,000 shares $76.59 million +14.5%12.6%4.4 $8.28 1/31/20258,080,000 shares $63.91 million -0.7%12.4%3.8 $7.91 1/15/20258,140,000 shares $58.93 million -22.0%12.5%4.5 $7.24 12/31/202410,440,000 shares $90.93 million +17.4%16.0%6.3 $8.71 12/15/20248,890,000 shares $85.61 million +21.6%13.6%5.9 $9.63 Get the Latest News and Ratings for KURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/30/20247,310,000 shares $80.70 million -33.7%11.2%5.8 $11.04 11/15/202411,030,000 shares $175.60 million +2.1%17.0%10.6 $15.92 10/31/202410,800,000 shares $180.58 million +16.3%16.4%20.8 $16.72 10/15/20249,290,000 shares $169.17 million -8.8%14.3%17 $18.21 9/30/202410,190,000 shares $199.11 million -5.2%15.7%17.6 $19.54 9/30/20245,430,000 shares $1.06 million +320.9%N/A1.9 $0.20 9/15/202410,750,000 shares $224.46 million -0.5%16.6%16.9 $20.88 9/15/20241,290,000 shares $214,656.00 +8.4%N/A0.4 $0.17 8/31/202410,800,000 shares $227.45 million +3.9%16.7%16 $21.06 8/31/20241,190,000 shares $222,173.00 -22.2%N/A0.2 $0.19 8/15/202410,400,000 shares $202.28 million +12.3%16.0%14.6 $19.45 8/15/20241,530,000 shares $289,017.00 -11.1%N/A0.2 $0.19 7/31/20249,260,000 shares $192.70 million +4.0%14.3%12.5 $20.81 7/31/20241,720,000 shares $381,152.00 +74.9%N/A0.2 $0.22 7/15/20248,900,000 shares $202.65 million +1.8%13.8%12 $22.77 7/15/2024983,600 shares $279,834.20 -65.5%N/A0.1 $0.28 6/30/20248,740,000 shares $179.96 million -11.2%13.5%11.8 $20.59 6/30/20242,850,000 shares $769,785.00 +99.3%N/A0.2 $0.27 6/15/20249,840,000 shares $204.87 million -0.4%15.2%13.7 $20.82 6/15/20241,430,000 shares $262,119.00 -69.8%N/A0.1 $0.18 5/31/20249,880,000 shares $203.63 million -4.2%15.3%12.5 $20.61 5/31/20244,740,000 shares $1.47 million +319.5%N/A0.3 $0.31 5/15/202410,310,000 shares $225.48 million -0.4%16.3%12.1 $21.87 5/15/20241,130,000 shares $148,143.00 -72.0%N/A0.1 $0.13 4/30/202410,350,000 shares $203.07 million +2.3%N/A11.4 $19.62 4/30/20244,040,000 shares $627,412.00 +477.1%N/A0.3 $0.16 4/15/202410,120,000 shares $192.38 million -2.8%15.9%7.2 $19.01 4/15/2024700,000 shares $77,070.00 +6.2%N/A0.1 $0.11 3/31/202410,410,000 shares $222.05 million +1.1%16.4%7.4 $21.33 3/31/2024658,900 shares $68,525.60 -70.1%N/A0 $0.10Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 3/15/202410,300,000 shares $230.10 million -6.5%16.2%7.3 $22.34 3/15/20242,200,000 shares $207,020.00 +0.5%N/A0.2 $0.09 2/29/202411,020,000 shares $232.30 million +4.9%17.4%7 $21.08 2/29/20242,190,000 shares $234,330.00 +432.7%N/A0.2 $0.11 2/15/202410,510,000 shares $215.56 million +12.2%16.3%7.1 $20.51 2/15/2024411,100 shares $44,028.81 +150.7%N/A0 $0.11 1/31/20249,370,000 shares $188.71 million No Change14.3%6.2 $20.14 1/31/2024164,000 shares $23,747.20 -59.7%5.0%0 $0.14 1/15/20249,370,000 shares $144.02 million +1.2%14.3%9.4 $15.37 1/15/2024407,100 shares $56,953.29 +234.8%12.3%0.1 $0.14 12/31/20239,260,000 shares $133.16 million -15.9%14.1%8.9 $14.38 12/31/2023121,600 shares $20,623.36 -60.4%3.7%0 $0.17 12/15/202311,010,000 shares $135.42 million -0.6%16.7%11.1 $12.30 12/15/2023306,900 shares $60,766.20 -12.8%9.3%0.3 $0.20 11/30/202311,080,000 shares $107.14 million +1.9%16.8%14.3 $9.67 11/30/2023352,000 shares $119,680.00 -34.6%10.9%0.5 $0.34 11/15/202310,870,000 shares $101.96 million +7.6%16.5%14.5 $9.38 11/15/2023538,500 shares $189,228.90 +541.8%32.3%1.3 $0.35 10/31/202310,100,000 shares $85.35 million +38.6%15.3%15.4 $8.45 10/31/202383,900 shares $62,664.91 +126.2%5.0%0.6 $0.75 10/15/20237,290,000 shares $61.53 million +4.1%11.1%11.4 $8.44 10/15/202337,100 shares $127,253.00 +152.4%2.2%2.1 $3.43 9/30/20237,000,000 shares $63.84 million +9.9%10.6%12.2 $9.12 9/30/202314,700 shares $59,388.00 +53.1%0.9%0.9 $4.04 9/15/20236,370,000 shares $63.00 million +3.8%9.7%10.3 $9.89 9/15/20239,600 shares $39,936.00 -66.6%0.6%0.1 $4.16 8/31/20236,140,000 shares $60.97 million -1.4%N/A7.8 $9.93 8/31/202328,700 shares $130,585.00 +38.0%1.8%0.2 $4.55 8/15/20236,230,000 shares $72.95 million +3.0%N/A7.2 $11.71 8/15/202320,800 shares $68,640.00 -23.3%1.2%0.1 $3.30 7/31/20236,050,000 shares $63.16 million -4.1%N/A6.8 $10.44 7/31/202327,100 shares $120,866.00 -46.6%1.6%0.2 $4.46 7/15/20236,310,000 shares $63.35 million +1.3%N/A7.1 $10.04 7/15/202350,700 shares $235,248.00 -9.8%3.1%0.3 $4.64 6/30/20236,230,000 shares $65.91 million -16.3%N/A7.2 $10.58 6/30/202356,200 shares $226,486.00 +200.5%3.4%0.3 $4.03 6/15/20237,440,000 shares $81.54 million +21.2%N/A9 $10.96 6/15/202318,700 shares $70,125.00 -26.4%1.1%0.5 $3.75 5/31/20236,140,000 shares $81.78 million -21.8%9.6%9.6 $13.32 5/31/202325,400 shares $81,534.00 +75.2%1.5%0.6 $3.21 5/15/20237,850,000 shares $99.38 million -0.4%12.4%12.5 $12.66 5/15/202314,500 shares $43,500.00 +12.4%0.9%0.3 $3.00 4/30/20237,880,000 shares $76.75 million -0.1%12.5%13.4 $9.74 4/30/202312,900 shares $35,733.00 -41.9%0.8%0.3 $2.77 4/15/20237,890,000 shares $90.26 million -3.8%12.5%12.9 $11.44 4/15/202322,200 shares $63,025.80 -12.9%1.4%0.9 $2.84 3/31/20238,200,000 shares $100.29 million +15.5%15.3%12.8 $12.23 3/31/202325,500 shares $89,989.50 +390.4%1.6%0.9 $3.53 3/15/20237,100,000 shares $83.00 million +0.1%11.0%10.6 $11.69 3/15/20235,200 shares $17,108.00 -85.4%0.3%0.1 $3.29The DOJ Just Said Your Money Isn’t Yours (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >> 2/28/20237,090,000 shares $84.51 million +5.4%11.0%8.6 $11.92 2/28/202335,600 shares $177,644.00 +65.6%2.2%0.5 $4.99 2/15/20236,730,000 shares $81.37 million +1.1%10.5%8.1 $12.09 2/15/202321,500 shares $130,075.00 +9.7%1.3%0.1 $6.05 1/31/20236,660,000 shares $92.04 million +5.4%10.3%7.5 $13.82 1/31/202319,600 shares $123,480.00 -14.4%1.2%0.1 $6.30 1/15/20236,320,000 shares $90.38 million -2.5%9.8%6.2 $14.30 1/15/202322,900 shares $162,819.00 -42.2%1.5%0.1 $7.11 12/30/20226,480,000 shares $80.42 million +2.4%10.0%6.2 $12.41 12/30/202239,600 shares $272,844.00 -56.3%2.7%0.1 $6.89 12/15/20226,330,000 shares $80.39 million -11.5%9.8%5.7 $12.70 12/15/202290,600 shares $834,426.00 -75.7%N/A0.2 $9.21 11/30/20227,150,000 shares $112.76 million +2.4%11.1%6.8 $15.77 11/30/2022373,400 shares $2.50 million +614.0%N/A1 $6.70 11/15/20226,980,000 shares $106.79 million +11.0%10.8%6.9 $15.30 11/15/202252,300 shares $208,154.00 -97.4%N/A0.9 $3.98 10/31/20226,290,000 shares $97.62 million -12.6%9.8%6.6 $15.52 10/31/20222,040,000 shares $219,708.00 +196.3%N/A0.9 $0.11 10/15/20227,200,000 shares $108.79 million -3.5%11.4%8.1 $15.11 10/15/2022688,400 shares $65,535.68 -16.8%N/A0.2 $0.10 9/30/20227,460,000 shares $101.90 million -7.8%11.8%8.4 $13.66 9/30/2022827,000 shares $89,316.00 +2.2%N/A0.3 $0.11 9/15/20228,090,000 shares $118.11 million -0.4%12.8%9.5 $14.60 9/15/2022808,900 shares $128,210.65 -11.3%N/A0.3 $0.16 8/31/20228,120,000 shares $112.54 million +4.5%12.8%10 $13.86 8/31/2022911,400 shares $141,358.14 -31.0%N/A0.3 $0.16 8/15/20227,770,000 shares $127.97 million +27.8%12.3%10 $16.47 8/15/20221,320,000 shares $245,784.00 +686.7%N/A0.4 $0.19 7/31/20226,080,000 shares $93.08 million +14.5%9.7%7.4 $15.31 7/31/2022167,800 shares $31,730.98 -56.4%N/A0 $0.19 7/15/20225,310,000 shares $95.26 million +9.3%8.4%7.1 $17.94 7/15/2022384,500 shares $94,548.55 -65.1%N/A0.1 $0.25 6/30/20224,860,000 shares $89.08 million +0.2%7.7%7.3 $18.33 6/30/20221,100,000 shares $305,800.00 +158.5%N/A0.3 $0.28 6/15/20224,850,000 shares $68.05 million +10.2%7.7%8 $14.03 6/15/2022425,500 shares $99,439.35 -35.1%N/A0.1 $0.23 5/31/20224,400,000 shares $57.90 million +7.8%7.0%7.5 $13.16 5/31/2022655,700 shares $118,026.00 +42.1%N/A0.2 $0.18 5/15/20224,080,000 shares $47.41 million +30.8%6.5%6.5 $11.62 5/15/2022461,600 shares $86,780.80 -64.5%N/A0.2 $0.19 4/30/20223,120,000 shares $44.77 million +8.7%5.0%4.2 $14.35 4/30/20221,300,000 shares $377,000.00 +157.6%N/A0.7 $0.29 4/15/20222,870,000 shares $46.29 million -1.4%4.6%3.5 $16.13 4/15/2022504,700 shares $160,999.30 +76.7%N/A0.4 $0.32 3/31/20222,910,000 shares $46.79 million -14.7%4.7%3.4 $16.08 3/31/2022285,600 shares $113,640.24 -17.5%N/A0.3 $0.40 3/15/20223,410,000 shares $51.46 million -15.6%5.5%3.9 $15.09 3/15/2022346,300 shares $107,353.00 +33.5%N/A0.7 $0.31 2/28/20224,040,000 shares $64.11 million -15.1%6.5%4.7 $15.87 2/28/2022259,400 shares $94,706.94 -59.0%N/A0.5 $0.37White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 2/15/20224,760,000 shares $68.07 million +24.6%7.6%4.9 $14.30 2/15/2022633,000 shares $294,978.00 -25.4%N/A1 $0.47 1/31/20223,820,000 shares $53.82 million +15.8%6.3%4.4 $14.09 1/31/2022849,000 shares $352,335.00 -5.2%N/A1.2 $0.42 1/15/20223,300,000 shares $45.01 million +2.5%5.4%4.5 $13.64 1/15/2022895,100 shares $428,752.90 +15.6%N/A0.9 $0.48 12/31/20213,220,000 shares $45.08 million -9.0%5.2%5.1 $14.00 12/31/2021774,500 shares $394,995.00 -14.3%N/A0.5 $0.51 12/15/20213,540,000 shares $46.62 million +1.7%5.7%5.6 $13.17 12/15/2021903,500 shares $575,529.50 -15.6%N/A0.4 $0.64 11/30/20213,480,000 shares $48.58 million -7.5%5.7%5.7 $13.96 11/30/20211,070,000 shares $749,000.00 +33.8%N/A0.5 $0.70 11/15/20213,760,000 shares $65.65 million -40.8%6.1%6.1 $17.46 11/15/2021799,600 shares $699,650.00 +148.9%N/A0.4 $0.88 10/29/20216,350,000 shares $104.27 million -2.0%10.4%11 $16.42 10/29/2021321,300 shares $280,494.90 -64.6%N/A0.2 $0.87 10/15/20216,480,000 shares $116.77 million -8.0%10.6%11.7 $18.02 10/15/2021907,100 shares $784,641.50 +24.2%N/A0.6 $0.87 9/30/20217,040,000 shares $131.86 million -1.7%11.5%11.9 $18.73 9/30/2021730,500 shares $628,376.10 -30.4%N/A0.8 $0.86 9/15/20217,160,000 shares $144.49 million -21.9%11.7%10.7 $20.18 9/15/20211,050,000 shares $1.41 million -14.6%3.9%1.3 $1.34 8/31/20219,170,000 shares $169.28 million +5.8%15.0%13 $18.46 8/31/20211,230,000 shares $1.87 million -1.6%4.5%1.8 $1.52 8/13/20218,670,000 shares $143.06 million +5.4%14.2%13.6 $16.50 8/13/20211,250,000 shares $1.94 million -2.3%4.6%1 $1.55 7/30/20218,230,000 shares $155.88 million +2.2%13.3%12.1 $18.94 7/30/20211,280,000 shares $1.97 million -21.0%4.7%1 $1.54 7/15/20218,050,000 shares $148.12 million -5.5%13.0%11.9 $18.40 7/15/20211,620,000 shares $2.61 million +22.7%5.9%1.3 $1.61 6/30/20218,520,000 shares $177.64 million -0.5%13.7%12.3 $20.85 6/30/20211,320,000 shares $3.00 million +13.8%4.8%1 $2.27 6/15/20218,560,000 shares $192.60 million +1.7%13.8%12.7 $22.50 6/15/20211,160,000 shares $2.12 million -35.2%4.3%1.4 $1.83 5/28/20218,420,000 shares $187.35 million -11.3%13.6%13.4 $22.25 5/28/20211,790,000 shares $2.88 million +506.0%6.6%2.2 $1.61 5/14/20219,490,000 shares $237.25 million +1.2%N/A12.1 $25.00 5/14/2021295,400 shares $384,020.00 -43.7%1.1%0.9 $1.30 4/30/20219,380,000 shares $257.86 million +6.6%N/A12.9 $27.49 4/30/2021524,300 shares $718,291.00 -15.8%2.0%0.7 $1.37 4/15/20218,800,000 shares $256.96 million -3.8%N/A11.7 $29.20 4/15/2021622,600 shares $1.00 million +1.5%2.5%0.6 $1.61 3/31/20219,150,000 shares $243.48 million +0.6%N/A12.3 $26.61 3/31/2021613,300 shares $1.09 million -32.9%2.5%0.6 $1.77 3/15/20219,100,000 shares $268.45 million +28.2%N/A11.6 $29.50 3/15/2021914,600 shares $1.97 million +4.7%3.7%0.8 $2.15 2/26/20217,100,000 shares $190.85 million +17.0%N/A7.6 $26.88 2/26/2021873,600 shares $1.73 million -4.6%3.7%0.8 $1.98 2/12/20216,070,000 shares $212.09 million +13.9%N/A7.3 $34.94 2/12/2021915,700 shares $2.36 million +53.4%3.9%0.8 $2.58Trump Predicts Dollar Downfall (Ad)READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now. 1/29/20215,330,000 shares $167.15 million -5.2%N/A6.4 $31.36 1/29/2021597,000 shares $1.13 million +285.4%3.3%0.7 $1.90 1/15/20215,620,000 shares $194.73 million -4.3%N/A6.7 $34.65 1/15/2021154,900 shares $215,311.00 No Change0.9%0.3 $1.39 12/31/20205,870,000 shares $199.52 million +15.8%N/A7 $33.99 12/15/20205,070,000 shares $209.59 million +8.3%N/A6.1 $41.34 11/30/20204,680,000 shares $170.26 million +8.1%N/A5.9 $36.38 11/15/20204,330,000 shares $173.03 million +25.9%N/A6 $39.96 10/30/20203,440,000 shares $109.91 million +8.5%N/A5 $31.95 10/15/20203,170,000 shares $105.97 million +5.7%N/A4.8 $33.43 9/30/20203,000,000 shares $91.92 million -22.5%N/A4.9 $30.64 9/15/20203,870,000 shares $109.64 million -5.2%N/A6.3 $28.33 8/31/20204,080,000 shares $101.55 million +3.3%N/A6.8 $24.89 8/31/2020434,400 shares $582,096.00 +32.4%N/A0.4 $1.34 8/14/20203,950,000 shares $82.91 million -1.5%N/A7 $20.99 8/14/2020328,000 shares $380,480.00 +33.0%N/A0.3 $1.16 7/31/2020246,600 shares $234,270.00 +55.7%N/A0.2 $0.95 7/31/20204,010,000 shares $65.92 million -1.5%N/A7.1 $16.44 7/15/20204,070,000 shares $72.93 million +6.8%9.7%5.4 $17.92 7/15/2020158,400 shares $107,712.00 -25.2%N/A0.2 $0.68 6/30/20203,810,000 shares $63.21 million +34.6%9.1%5.2 $16.59 6/30/2020211,700 shares $142,918.67 -53.8%N/A0.3 $0.68 6/15/20202,830,000 shares $47.83 million +2.5%6.7%3.9 $16.90 6/15/2020458,100 shares $508,491.00 +14.7%N/A0.8 $1.11 5/29/20202,760,000 shares $45.95 million -1.4%6.7%4.1 $16.65 5/29/2020399,400 shares $411,382.00 +20.3%N/A1 $1.03 KURA Short Interest - Frequently Asked Questions What is Kura Oncology's current short interest? Short interest is the volume of Kura Oncology shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 8,280,000 shares of KURA short. Learn More on Kura Oncology's current short interest. What is a good short interest ratio for Kura Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KURA shares currently have a short interest ratio of 6.0. Learn More on Kura Oncology's short interest ratio. Which institutional investors are shorting Kura Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kura Oncology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Kura Oncology's short interest increasing or decreasing? Kura Oncology saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 8,280,000 shares, a drop of 4.6% from the previous total of 8,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kura Oncology's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kura Oncology: Kymera Therapeutics, Inc. (11.03%), Biohaven Ltd. (7.65%), ImmunityBio, Inc. (7.79%), Harmony Biosciences Holdings, Inc. (7.46%), Twist Bioscience Co. (16.62%), Belite Bio, Inc (0.23%), Kiniksa Pharmaceuticals, Ltd. (4.56%), Arrowhead Pharmaceuticals, Inc. (9.80%), CG Oncology, Inc. (24.37%), Travere Therapeutics, Inc. (11.98%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Kura Oncology stock? Short selling KURA is an investing strategy that aims to generate trading profit from Kura Oncology as its price is falling. KURA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kura Oncology? A short squeeze for Kura Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KURA, which in turn drives the price of the stock up even further. How often is Kura Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KURA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies KYMR Short Interest Data BHVN Short Interest Data IBRX Short Interest Data HRMY Short Interest Data TWST Short Interest Data BLTE Short Interest Data KNSA Short Interest Data ARWR Short Interest Data CGON Short Interest Data TVTX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KURA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.